News

Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market ...
While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts ...
A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...